TrialAIDS research and therapy2022

Immunogenicity of personalized dendritic-cell therapy in HIV-1 infected individuals under suppressive antiretroviral treatment: interim analysis from a phase II clinical trial.

Marcella Vassão de Almeida Baptista et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.